#pancreatic-cancer

#pancreatic-cancer

A trial is to assess the effectiveness of a world-first breath test for the disease, which is notoriously hard to spot in its early stages. Pancreatic Cancer UK, which is funding the study, said the launch of the trial was "the most significant step toward a lifesaving-breakthrough in 50 years". Vague symptoms of the disease, including back pain and indigestion, mean the disease is often not detected until it has spread to other parts of the body.

"Dick doesn't know anything about rock or punk or jazz or classical, and he doesn't care to know... What he does know is soul and oldies, and especially girl groups from the 1960s."

In 2022, NIST began the Cancer Genome in a Bottle program, aiming to sequence cancer genomes for improved detection and treatment accuracy, with expectations of results in a decade.

In our original article, we identified a key issue in the visualization of metabolite concentrations. Specifically, values below 100 ng/ml were wrongly formatted, which impacted figures.